Department of Medicine

A clinical trial supports approval of a new medication to treat moderate-to-severe asthma in children.

Study explores role RSV plays in later asthma development

A Vanderbilt clinical project will follow 1,950 Middle Tennessee children to determine how genes and the environment interact with RSV infection during the first year of life and contribute to asthma development

VIGH, VICC establish cancer research program in Zambia

Vanderbilt University Medical Center and the University of Zambia (UNZA) are partnering on a program to develop a cadre of researchers and educators to lead cancer epidemiology research and training in Zambia.

Longtime division leader earns degree, accolades

Vanderbilt’s Amy Shelton, MS, has been awarded a Master of Science Degree in Research Administration with Honors from the Johns Hopkins University Krieger School of Arts and Sciences.

The study team included (front row, from left) Kelsey Voss, PhD, Rachel Bonami, PhD, Erin Wilfong, MD, PhD, (back row, from left) Jonathan Irish, PhD, Jeff Rathmell, PhD, and Ivelin Georgiev, PhD.

Vanderbilt team tracks cellular and antibody responses to COVID-19 vaccine

In a technical tour de force, a collaborative team of Vanderbilt researchers has characterized the antigen-specific immune response to the Pfizer SARS-CoV-2 RNA vaccine.

Holowatyj named chair of scientific advisory board for ACPMP Research Foundation

Vanderbilt’s Andreana Holowatyj, PhD, MSCI, has been named the inaugural chair of the scientific advisory board for the Appendix Cancer Pseudomyxoma Peritonei Research Foundation.

Heart patient Gabe Ezell, 11, recently visited Children’s Hospital’s new Fontan Clinic to check on his overall health in addition to his congenital heart condition. In the photo above, Gabe visits with Fontan team members Anita Pai, MD, left, and Angela Weingarten, MD.

Clinic offers ongoing care for pediatric heart patients

Vanderbilt recently launched a new multidisciplinary Fontan Clinic, which will provide an ongoing, coordinated care plan for children and teens, ages 10-19, who have had the Fontan procedure for single ventricle heart disease.

1 42 43 44 45 46 125